Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 12, 2022
Patent Application Number
16537075
Date Filed
August 9, 2019
Patent Citations
Patent Primary Examiner
Disclosed is an antibody which binds to paliperidone, which can be used to detect paliperidone in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of paliperidone, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone/paliperidone in a single lateral flow assay device.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.

